Exact Mass: 614.406

Exact Mass Matches: 614.406

Found 74 metabolites which its exact mass value is equals to given mass value 614.406, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

CHAPS

3-((3-Cholamidopropyl)dimethylammonium)-1-propanesulfonate

C32H58N2O7S (614.3965)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents

   

Antibiotic X 14889C

2-[6-(6-{5-[5-ethyl-2-hydroxy-5-(1-hydroxyethyl)-3-methyloxolan-2-yl]-3,5-dimethyloxolan-2-yl}-3-hydroxy-4-methyl-5-oxooctan-2-yl)-2-hydroxy-3,5-dimethyloxan-2-yl]acetic acid

C33H58O10 (614.403)


Ruminant feed additive. Ruminant feed additive

   

(6S,3'S,5'R,6'R)-6,3',5'-Trihydroxy-4,5,6',7'-tetradehydro-7,8,5',6'-tetrahydro-beta,beta-carotene-3,8-dione

4-[18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15,17-octaen-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)


   

Chaps

3-[Dimethyl[3-[(R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanamido]propyl]ammonio]propane-1-sulfonate

C32H58N2O7S (614.3965)


   

Iron linoleate

λ²-iron(2+) ion bis((9Z,12Z)-octadeca-9,12-dienoate)

C36H62FeO4 (614.3997)


It is used as a food additive .

   

(2R,2R,3S,3R)-2,2,3,3-Tetrahydroxy-beta,beta-caroten-4-one

(2R,2R,3S,3R)-2,2,3,3-Tetrahydroxy-beta,beta-caroten-4-one

C40H54O5 (614.3971)


   

19-Hydroxymytiloxanthin

(3R,3S,5R)-7,8-Didehydro-3,19,3,8-tetrahydroxy-beta,kappa-caroten-6-one

C40H54O5 (614.3971)


   

4-Hydroxymytiloxanthin

(3S,3S,4S,5R)-7,8-Didehydro-3,3,4,8-tetrahydroxy-beta,kappa-caroten-6-one

C40H54O5 (614.3971)


   

Amarouciaxanthin A

(3S,5R,6R,6S)-3,5,6-Trihydroxy-6,7-didehydro-5,6,7,8-tetrahydro-beta,epsilon-carotene-3,8-dione

C40H54O5 (614.3971)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids Window width to select the precursor ion was 3 Da.; CONE_VOLTAGE was 10 V.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. Window width to select the precursor ion was 3 Da.; CONE_VOLTAGE was 20 V.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.

   

uriolide

(3S,5R,6S,3R,6R)-5,6-Epoxy-3,3-dihydroxy-5,6,7,8-tetrahydro-beta,epsilon-caroten-19,11-olide

C40H54O5 (614.3971)


   

12-hydroxyabieta-8,11,13-trien-7beta-yl 6-hydroxy-7-oxoabieta-5,8,11,13-tetraen-12-yl peroxide|obtusanol B

12-hydroxyabieta-8,11,13-trien-7beta-yl 6-hydroxy-7-oxoabieta-5,8,11,13-tetraen-12-yl peroxide|obtusanol B

C40H54O5 (614.3971)


   

3beta-[(E)-3-(4-methoxyphenyl)acryloxy]urs-11-en-28,13beta-olide|ehretiolide

3beta-[(E)-3-(4-methoxyphenyl)acryloxy]urs-11-en-28,13beta-olide|ehretiolide

C40H54O5 (614.3971)


   

(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-5alpha-cholestane-3beta,4beta,8,15alpha,16beta,26-hexol|kurilensoside E

(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-5alpha-cholestane-3beta,4beta,8,15alpha,16beta,26-hexol|kurilensoside E

C33H58O10 (614.403)


   

(20R,24S)-24-O-(beta-D-glucopyranosyl)-5alpha-cholestan-3beta,6alpha,8,15beta,24-pentaol|(20R,24S)-24-O-(beta-D-glucopyranosyl)-5alpha-cholestane-3beta,6alpha,8,15beta,4-pentaol|evasterioside D

(20R,24S)-24-O-(beta-D-glucopyranosyl)-5alpha-cholestan-3beta,6alpha,8,15beta,24-pentaol|(20R,24S)-24-O-(beta-D-glucopyranosyl)-5alpha-cholestane-3beta,6alpha,8,15beta,4-pentaol|evasterioside D

C33H58O10 (614.403)


   

lincoside L1

lincoside L1

C33H58O10 (614.403)


   

4,4-dihydroxyadonixanthin

4,4-dihydroxyadonixanthin

C40H54O5 (614.3971)


   

Lys Arg Arg Arg

(2S)-5-carbamimidamido-2-[(2S)-5-carbamimidamido-2-[(2S)-5-carbamimidamido-2-[(2S)-2,6-diaminohexanamido]pentanamido]pentanamido]pentanoic acid

C24H50N14O5 (614.4088)


   

Arg Lys Arg Arg

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-5-carbamimidamidopentanamido]hexanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C24H50N14O5 (614.4088)


   

Arg Arg Lys Arg

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]hexanamido]-5-carbamimidamidopentanoic acid

C24H50N14O5 (614.4088)


   

Arg Arg Arg Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]hexanoic acid

C24H50N14O5 (614.4088)


   

4-Ketonostoxanthin

(2R,3S,2R,3R)-2,3,2,3-Tetrahydroxy-beta,beta-caroten-4-one

C40H54O5 (614.3971)


   

Evasterioside D

(20R,24S)-24-O-(beta-D-glucopyranosyl)-5alpha-cholestane-3beta,6alpha,8,15beta,24-pentaol

C33H58O10 (614.403)


   

Kurilensoside E

(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-5alpha-cholestane-3beta,4beta,8,15alpha,16beta,26-hexol

C33H58O10 (614.403)


   

X 14889C

2-[6-(6-{5-[5-ethyl-2-hydroxy-5-(1-hydroxyethyl)-3-methyloxolan-2-yl]-3,5-dimethyloxolan-2-yl}-3-hydroxy-4-methyl-5-oxooctan-2-yl)-2-hydroxy-3,5-dimethyloxan-2-yl]acetic acid

C33H58O10 (614.403)


   

(3R,3R,5S)-3,3,5,19-tetrahydroxy-7,8-didehydro-gamma,epsilon-carotene-8-one

(3R,3R,5S)-3,3,5,19-tetrahydroxy-7,8-didehydro-gamma,epsilon-carotene-8-one

C40H54O5 (614.3971)


   

SLIGKV-NH2

SLIGKV-NH2

C28H54N8O7 (614.4115)


Protease-Activated Receptor-2, amide (SLIGKV-NH2) is a highly potent protease-activated receptor-2 (PAR2) activating peptide.

   

2,2-Dihydroxyadonixanthin

2,2-Dihydroxyadonixanthin

C40H54O5 (614.3971)


   

(6S,3S,5R,6R)-6,3,5-Trihydroxy-4,5,6,7-tetradehydro-7,8,5,6-tetrahydro-beta,beta-carotene-3,8-dione

(6S,3S,5R,6R)-6,3,5-Trihydroxy-4,5,6,7-tetradehydro-7,8,5,6-tetrahydro-beta,beta-carotene-3,8-dione

C40H54O5 (614.3971)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

PE-Cer 12:2;2O/18:2;O

PE-Cer 12:2;2O/18:2;O

C32H59N2O7P (614.406)


   

PE-Cer 18:3;2O/12:1;O

PE-Cer 18:3;2O/12:1;O

C32H59N2O7P (614.406)


   

PE-Cer 14:3;2O/16:1;O

PE-Cer 14:3;2O/16:1;O

C32H59N2O7P (614.406)


   

PE-Cer 16:3;2O/14:1;O

PE-Cer 16:3;2O/14:1;O

C32H59N2O7P (614.406)


   

PE-Cer 17:3;2O/13:1;O

PE-Cer 17:3;2O/13:1;O

C32H59N2O7P (614.406)


   

PE-Cer 14:2;2O/16:2;O

PE-Cer 14:2;2O/16:2;O

C32H59N2O7P (614.406)


   

PE-Cer 15:3;2O/15:1;O

PE-Cer 15:3;2O/15:1;O

C32H59N2O7P (614.406)


   

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C33H58O10 (614.403)


   

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C33H58O10 (614.403)


   

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C33H58O10 (614.403)


   

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C33H58O10 (614.403)


   

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C33H58O10 (614.403)


   

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C33H58O10 (614.403)


   

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C33H58O10 (614.403)


   

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H56NO7+ (614.4057)


   

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C36H56NO7+ (614.4057)


   

Antibiotic X 14889C

Antibiotic X 14889C

C33H58O10 (614.403)


   

MGDG O-24:3;O

MGDG O-24:3;O

C33H58O10 (614.403)


   
   

CerPE 12:2;O2/18:2;O

CerPE 12:2;O2/18:2;O

C32H59N2O7P (614.406)


   

ST 27:0;O5;Hex

ST 27:0;O5;Hex

C33H58O10 (614.403)


   

VKGILS-NH2

VKGILS-NH2

C28H54N8O7 (614.4115)


VKGILS-NH2 is a reversed amino acid sequence control peptide for SLIGKV-NH2 (protease-activated receptor 2 (PAR2) agonist). VKGILS-NH2 has no effect on DNA synthesis in cells[1][2].

   

(1r,3r,3as,3bs,5r,5as,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

(1r,3r,3as,3bs,5r,5as,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

C33H58O10 (614.403)


   

7-[(4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

7-[(4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

C33H58O10 (614.403)


   

4-[(3e,5e,7e,9e,11e,13e,15e)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15,17-octaen-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

4-[(3e,5e,7e,9e,11e,13e,15e)-18-(2,4-dihydroxy-2,6,6-trimethylcyclohexylidene)-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15,17-octaen-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)


   

(5r,6s)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r,5r)-4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

(5r,6s)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r,5r)-4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)


   

(3r,6s,9r,12r,15s)-3-isopropyl-12-{[4-(methylamino)phenyl]methyl}-6,9,15-tris(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

(3r,6s,9r,12r,15s)-3-isopropyl-12-{[4-(methylamino)phenyl]methyl}-6,9,15-tris(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)


   

3-[(1e,3e,5e,7e,9e)-18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

3-[(1e,3e,5e,7e,9e)-18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)


   

(5s,6r)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r,5r)-4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

(5s,6r)-3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(4r,5r)-4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)


   

9a,11a-dimethyl-1-(6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

9a,11a-dimethyl-1-(6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl)-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C33H58O10 (614.403)


   

(4s)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15,17-octaen-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

(4s)-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(2r,4s)-2,4-dihydroxy-2,6,6-trimethylcyclohexylidene]-3,7,12,16-tetramethyl-2-oxooctadeca-3,5,7,9,11,13,15,17-octaen-1-yl]-4-hydroxy-3,5,5-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)


   

3-isopropyl-12-{[4-(methylamino)phenyl]methyl}-6,9,15-tris(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

3-isopropyl-12-{[4-(methylamino)phenyl]methyl}-6,9,15-tris(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)


   

7-[(4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-1-(7-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-2,3,3b,6-tetrol

7-[(4,5-dihydroxy-3-methoxyoxan-2-yl)oxy]-1-(7-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-2,3,3b,6-tetrol

C33H58O10 (614.403)


   

(3r,6s,9r,12s,15r)-3-[(4-aminophenyl)methyl]-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

(3r,6s,9r,12s,15r)-3-[(4-aminophenyl)methyl]-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)


   

(4ar)-6-{[(4as,9s,10as)-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl]peroxy}-10-hydroxy-7-isopropyl-1,1,4a-trimethyl-3,4-dihydro-2h-phenanthren-9-one

(4ar)-6-{[(4as,9s,10as)-6-hydroxy-7-isopropyl-1,1,4a-trimethyl-2,3,4,9,10,10a-hexahydrophenanthren-9-yl]peroxy}-10-hydroxy-7-isopropyl-1,1,4a-trimethyl-3,4-dihydro-2h-phenanthren-9-one

C40H54O5 (614.3971)


   

(1r,9r,11r,15s,19r,22r,27r,28s)-4,9-dihydroxy-6-isopropyl-5-methoxy-12,12,23,23,27-pentamethyloctacyclo[17.11.1.0¹,¹⁷.0²,¹¹.0²,¹⁵.0³,⁸.0¹⁹,²⁸.0²²,²⁷]hentriaconta-3,5,7,16-tetraene-13,18-dione

(1r,9r,11r,15s,19r,22r,27r,28s)-4,9-dihydroxy-6-isopropyl-5-methoxy-12,12,23,23,27-pentamethyloctacyclo[17.11.1.0¹,¹⁷.0²,¹¹.0²,¹⁵.0³,⁸.0¹⁹,²⁸.0²²,²⁷]hentriaconta-3,5,7,16-tetraene-13,18-dione

C40H54O5 (614.3971)


   

3-[18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

3-[18-(4,5-dihydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-5,6-dihydroxy-2,4,4-trimethylcyclohex-2-en-1-one

C40H54O5 (614.3971)


   

(1r,3r,3as,3bs,5s,5as,7s,9as,9br,11ar)-9a,11a-dimethyl-1-[(2r,5s)-6-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

(1r,3r,3as,3bs,5s,5as,7s,9as,9br,11ar)-9a,11a-dimethyl-1-[(2r,5s)-6-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-2-yl]-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C33H58O10 (614.403)


   

3-[(4-aminophenyl)methyl]-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

3-[(4-aminophenyl)methyl]-6,9,12,15-tetrakis(2-methylpropyl)-1,4,7,10,13-pentaazacyclopentadeca-1,4,7,10,13-pentaene-2,5,8,11,14-pentol

C33H54N6O5 (614.4155)


   

(1r,2r,3r,3as,3bs,5ar,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-2,3,3b,6-tetrol

(1r,2r,3r,3as,3bs,5ar,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-2,3,3b,6-tetrol

C33H58O10 (614.403)


   

2-(6-{6-[5'-ethyl-2'-hydroxy-5'-(1-hydroxyethyl)-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl}-3,5-dimethyloxan-2-yl)ethaneperoxoic acid

2-(6-{6-[5'-ethyl-2'-hydroxy-5'-(1-hydroxyethyl)-2,3',4-trimethyl-[2,2'-bioxolan]-5-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl}-3,5-dimethyloxan-2-yl)ethaneperoxoic acid

C33H58O10 (614.403)


   

(1r,3s,3as,3bs,5r,5as,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

(1r,3s,3as,3bs,5r,5as,6r,7s,9as,9br,11ar)-7-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy}-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6-tetrol

C33H58O10 (614.403)


   

(2z,4e,6e,8e,10e,12e,14e,16z)-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-19-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-17-(hydroxymethyl)-4,8,13-trimethylnonadeca-2,4,6,8,10,12,14,16-octaen-18-yn-1-one

(2z,4e,6e,8e,10e,12e,14e,16z)-3-hydroxy-1-[(1r,4s)-4-hydroxy-1,2,2-trimethylcyclopentyl]-19-[(4r)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-17-(hydroxymethyl)-4,8,13-trimethylnonadeca-2,4,6,8,10,12,14,16-octaen-18-yn-1-one

C40H54O5 (614.3971)


   

(1r,3s)-6-[(3e,5e,7e,9e,11e,13e,15z)-17-hydroxy-16-{2-[(1r,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]ethynyl}-3,7,12-trimethylheptadeca-1,3,5,7,9,11,13,15-octaen-1-ylidene]-1,5,5-trimethylcyclohexane-1,3-diol

(1r,3s)-6-[(3e,5e,7e,9e,11e,13e,15z)-17-hydroxy-16-{2-[(1r,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]ethynyl}-3,7,12-trimethylheptadeca-1,3,5,7,9,11,13,15-octaen-1-ylidene]-1,5,5-trimethylcyclohexane-1,3-diol

C40H54O5 (614.3971)